Level D· Scientific groundwork from lab and animal studiesNarrative ReviewEurope PMCOpen access

From light to healing: photobiomodulation therapy in medical disciplines

Shivappa P., Basha S., Biswas S., Prabhu V., Prabhu SS., Pai AR.

Narrative Review on Chronic Wound, published in J Transl Med (2025) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
J Transl Med (2025)
Reported sample size
—
Source database
Europe PMC
PMID
41466382
PMCID
PMC12751248
DOI
10.1186/s12967-025-07466-3
Citations
6

Abstract (original English)

Background Photobiomodulation therapy (PBMT) represents a rapidly expanding area of translational research that bridges photophysics, mitochondrial biology, and clinical rehabilitation. It leverages low-level light to modulate cellular bioenergetics, inflammatory signaling, and tissue repair processes across various medical disciplines. Methods A systematic literature search was conducted using Google Scholar, Scopus, PubMed, and Web of Science to identify recent clinical and mechanistic studies on PBMT. The gathered evidence was analyzed to evaluate the influence of PBMT on cytochrome c oxidase-mediated energy transduction, reactive oxygen species modulation, nitric oxide signaling, and cytokine regulation. Results Current findings indicate that PBMT exerts multifaceted effects on metabolism and immune homeostasis. Clinical applications have expanded from dermatology and wound healing to musculoskeletal, neurological, ophthalmic, and oncologic conditions. PBMT shows potential for symptom alleviation, accelerated recovery, and tissue protection under oxidative or inflammatory stress. However, translation from preclinical evidence to consistent clinical outcomes remains constrained by non-standardized dosimetry, inconsistent energy delivery, and heterogeneous study endpoints. Negative or equivocal outcomes in trials involving trained or low-stress cohorts highlight the context-d

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
AnimalsHumansWound HealingLow-Level Light Therapy

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research